Disability rights advocates are filing lawsuits as students, teachers and parents organize to protect education.

AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through innovative bispecific antibodies, today announced that it will present a preclinical ...

Under the terms of the agreement, Cloudastructure has issued 3,000 shares of Series 2 Convertible Preferred Stock at a purchase price of $1,000 per share. The Series 2 Preferred Stock carries a 9.5% ...